These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19128049)

  • 1. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.
    White KY; Rodemich L; Nyalwidhe JO; Comunale MA; Clements MA; Lance RS; Schellhammer PF; Mehta AS; Semmes OJ; Drake RR
    J Proteome Res; 2009 Feb; 8(2):620-30. PubMed ID: 19128049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma.
    Sarrats A; Saldova R; Comet J; O'Donoghue N; de Llorens R; Rudd PM; Peracaula R
    OMICS; 2010 Aug; 14(4):465-74. PubMed ID: 20726802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
    Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
    Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
    Tajiri M; Ohyama C; Wada Y
    Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
    Peracaula R; Tabarés G; Royle L; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
    Glycobiology; 2003 Jun; 13(6):457-70. PubMed ID: 12626390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
    Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
    Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease.
    Drake RR; White KY; Fuller TW; Igwe E; Clements MA; Nyalwidhe JO; Given RW; Lance RS; Semmes OJ
    J Proteomics; 2009 Aug; 72(6):907-17. PubMed ID: 19457353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.
    de Leoz ML; An HJ; Kronewitter S; Kim J; Beecroft S; Vinall R; Miyamoto S; de Vere White R; Lam KS; Lebrilla C
    Dis Markers; 2008; 25(4-5):243-58. PubMed ID: 19126968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?
    Omacini S; Mione R; Barichello M; Santucci Delli Ponti U; Bolgan A; Contemori GP; Petracco S; Capitanio G; Donisi PM; Gion M
    Eur Urol; 1992; 21 Suppl 1():108-10. PubMed ID: 1385128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
    Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
    Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.
    Nyalwidhe JO; Betesh LR; Powers TW; Jones EE; White KY; Burch TC; Brooks J; Watson MT; Lance RS; Troyer DA; Semmes OJ; Mehta A; Drake RR
    Proteomics Clin Appl; 2013 Oct; 7(9-10):677-89. PubMed ID: 23775902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the human seminal plasma glycome reveals the presence of immunomodulatory carbohydrate functional groups.
    Pang PC; Tissot B; Drobnis EZ; Morris HR; Dell A; Clark GF
    J Proteome Res; 2009 Nov; 8(11):4906-15. PubMed ID: 19606896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.
    Turkes A; Nott J; Turkes AO; Griffiths K
    Am J Clin Oncol; 1988; 11 Suppl 2():S77-9. PubMed ID: 2468280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of molecular species of prostate-specific antigen complexed with immunoglobulin M in prostate cancer and benign prostatic hyperplasia.
    Goč S; Janković M
    Dis Markers; 2013; 35(6):847-55. PubMed ID: 24367138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Secretory Protein of 94 amino acids (PSP94) binds to prostatic acid phosphatase (PAP) in human seminal plasma.
    Anklesaria JH; Jagtap DD; Pathak BR; Kadam KM; Joseph S; Mahale SD
    PLoS One; 2013; 8(3):e58631. PubMed ID: 23469287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha(1)-antichymotrypsin (PSA-ACT).
    Peter J; Unverzagt C; Hoesel W
    Clin Chem; 2000 Apr; 46(4):474-82. PubMed ID: 10759471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma.
    Huang CL; Brassil D; Rozzell M; Schellhammer PF; Wright GL
    Prostate; 1993; 23(3):201-12. PubMed ID: 7694265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
    Buamah PK; Johnson P; Skillen AW
    Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b.
    Harvey AM; Grice B; Hamilton C; Truong LD; Ro JY; Ayala AG; Zhai QJ
    Arch Pathol Lab Med; 2010 Jul; 134(7):983-8. PubMed ID: 20586625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput quantitative analysis of total N-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Jeong HJ; Kim YG; Yang YH; Kim BG
    Anal Chem; 2012 Apr; 84(7):3453-60. PubMed ID: 22455307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.